Nogal Medicine Switzerland

NogalMedicine is a pioneering medical technology (MedTech) company at the forefront of innovation in eye care. With a portfolio of groundbreaking technologies in the pipeline, one of our flagship innovations is our state-of-the-art Tonometer. Our company is driven by a commitment to revolutionize eye care and make a significant impact on global health. Our Holistic approach to medicine as well to business creates unique proposition to our business partners and patients. Tonometer: A Game-Changing Breakthrough device. Our Tonometer is ready to revolutionaize the field of eye care with its unique capabilities and competitive advantages: Preventing Blindness in Glaucoma: our Tonometer offers a groundbreaking approach to prevent blindness in all types of glaucoma, including normal-tension glaucoma (NTG). By non-invasively measuring clinically significant intraocular pressure in the posterior segment of the eye—where optic nerve structures are susceptible to damage—we provide a vital diagnostic tool for early intervention and treatment. Diagnosing Pupillary Block: we are proud to introduce the world's first measurement of pupillary outflow resistance. This innovation facilitates the early detection of suspected pupillary block, enabling timely and relevant drug or surgical treatments. Personalized Eye Assessment: our Tonometer goes beyond generic assessments. It provides a personalized evaluation of variable eye parameters that contribute to glaucoma risk. This capability allows us to determine an individual's "relative intraocular hypertension," a critical factor in optic nerve atrophy. Social Impact: by preventing glaucoma-related blindness, our technology offers immense social and economic benefits. Globally, government health organizations can save significant healthcare costs. In the United States alone, glaucoma incurs an estimated $2.5 billion annually in healthcare expenses, with $1.9 billion attributed to direct medical costs (Glaucoma Today).

• Employees 3
• Founded 2020